Eric Wombwell – Advancing Antibiotic Selection for Common Outpatient Infections – PESI

*** Proof of Product ***

---

Exploring the Essential Features of “Eric Wombwell – Advancing Antibiotic Selection for Common Outpatient Infections – PESI”

Advancing Antibiotic Selection for Common Outpatient Infections
Speaker: Eric Wombwell, PharmD, BCIDP
Format: Audio and Video

Description

New research, clinical practice guidelines, and bacterial resistance continues to alter best practice for use of antibiotics. This session will emphasize results from recent research publications that demonstrate opportunities for enhanced antibiotic use to optimize patient outcomes. Dr. Wombwell, PharmD and Board Certified Infectious Disease Pharmacist, will draw attention to clinical situations that antibiotics are overprescribed, unnecessarily used, inappropriately dosed and underutilized in the treatment of infections.

Speaker

Eric Wombwell, PharmD, BCIDP
Dr. Eric Wombwell is a board-certified infectious diseases pharmacist and clinical associate professor for the Department of Pharmacy Practice and Administration at the University of Missouri – Kansas City, School of Pharmacy. Eric completed his PharmD degree at the University of Missouri Kansas City, followed by an ASHP accredited pharmacy practice residency at the Kansas City VA Medical Center. Following residency, he accepted a full-time non-tenured clinical faculty position at the University of Missouri – Kansas City, School of Pharmacy. His teaching responsibilities include infectious diseases topics throughout the curriculum. Eric also has a clinical appointment at Centerpoint Medical Center rounding with the infectious diseases consult team and supporting antimicrobial stewardship efforts at the facility.

Eric is regularly published in pharmacy and infectious diseases research and is frequently invited to deliver continuing education presentations locally and nationally to various health-professional audiences. He is recognized for excellence in teaching through various awards, including the “Missouri Pharmacist Association – UMKC Faculty Member of the Year”, and the “University of Missouri – Kansas City Provost’s Award for Excellence in Teaching”.

Speaker Disclosures:
Financial: Eric Wombwell has an employment relationship with the University of Missouri. He receives a speaking honorarium, recording royalties, and a consulting fee from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Eric Wombwell is a member of the Society of Infectious Diseases Pharmacists, the Missouri Pharmacists Association, American Association of Colleges of Pharmacy, Infectious Diseases Society of America, and Centerpoint Medical Center. 

Objectives

1. Evaluate beta-lactam reaction histories to makes evidence-based decisions on the need to avoid beta-lactam therapies.
2. Develop risk factor–based empiric antibiotic regimens for patients with suspected community-acquired pneumonia.
3. Conclude which clinical scenarios require MRSA coverage for skin infections.
4. Formulate effective evidence-based therapies for Clostridioides difficile infections.
5. Choose cost-effective antibiotic therapies that minimize risk for adverse effects.

Outline

Penicillin Allergy

• Side effect vs. allergy
• Reassessing allergy statistics
• Cephalosporin cross-sensitivity
• Allergy history and antibiotic indication-based recommendations

Community Acquired Pneumonia

• Assess 2019 ATS/IDSA guidelines
• Review EPIC study
• Streptococcus pneumonia resistance
• Evaluate and contrast oral therapies for CAP

Skin Infections

• Assessing Streptococcus vs. Staphylococcus
• When is MRSA therapy necessary?
• Comparison of oral MRSA therapies
• NSAID adjunct

C. difficile Infections

• Vancomycin vs. Fidaxomicin
• Managing recurrence
• Probiotic assessment

Target Audience

• Nurses
• Nurse Practitioners
• Physicians
• Physicians Assistants

Please see the full list of alternative group-buy courses available here: https://lunacourse.com/shop/